Congenital adrenal hyperplasia in adults

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 17, Issue 3, 2010, Pages 210-216

  Auchus, Richard J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

21 hydroxylase deficiency; 46XX DSD; Adrenal gland; Androgen; Congenital adrenal hyperplasia; Steroidogenesis; Testicular adrenal rest tissue; Virilization

Indexed keywords

DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; PRASTERONE SULFATE; PREDNISOLONE; PREDNISONE; SEX HORMONE BINDING GLOBULIN; SPIRONOLACTONE;

ADRENAL CORTEX TUMOR; ADRENAL HYPERPLASIA; ADRENALECTOMY; AZOOSPERMIA; BLOOD PRESSURE REGULATION; BONE DENSITY; CHEEK MUCOSA; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN TEST; CROSS-SECTIONAL STUDY; CUSHING SYNDROME; DEPRESSION; FEMALE INFERTILITY; FERTILIZATION; GENETIC DISORDER; GOAL ATTAINMENT; HIGH SODIUM INTAKE; HIRSUTISM; HUMAN; LEYDIG CELL; LONGITUDINAL STUDY; LOW DRUG DOSE; MALE INFERTILITY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INHIBITION; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT WASTING; SEXUAL BEHAVIOR; SIDE EFFECT; SPERMATOZOON COUNT; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROIDOGENESIS; TESTICULAR ENLARGEMENT; TESTIS ATROPHY; TESTIS FUNCTION; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL; VAGINA RECONSTRUCTION; WEAKNESS; WEIGHT GAIN;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; GLUCOCORTICOIDS; HUMANS; INFERTILITY; NEOPLASMS; QUALITY OF LIFE; STEROID 21-HYDROXYLASE;

EID: 77951853605     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32833961d7     Document Type: Review

References (49)

1. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003; 349:776-788.
2. Therrell BLJ, Berenbaum SA, Manter-Kapanke V, et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 1998; 101:583-590. (Pubitemid 28180138)
3. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21- hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 2002; 87:4048-4053.
4. Speiser PW, Agdere L, Veshiba H, et al. Aldosterone synthesis in patients with salt-wasting congenital adrenal hyperplasia (21-hydroxylase deficiency) and complete absence of adrenal 21-hydroxylase (P450c21). New Engl J Med 1991; 321:145-149.
5. Moore GW, Lacroix A, Rabin D, McKenna TJ. Gonadal dysfunction in adult men with congenital adrenal hyperplasia. Acta Endocrinol (Copenh) 1980; 95:185-193. (Pubitemid 11218635)
6. Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, et al. Serum 21- deoxycortisol, 17-hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11b-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91:2179-2184. (Pubitemid 43855002)
7. Nakamura Y, Hornsby PJ, Casson P, et al. Type 5 17b-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis. J Clin Endocrinol Metab 2009; 94:2192-2198.
8. Mahendroo MS, Wilson JD, Richardson JA, Auchus RJ. Steroid 5a-reductase 1 promotes 5a-androstane-3a,17b-diol synthesis in immature mouse testes by two pathways. Mol Cell Endocrinol 2004; 222:113-120.
9. Wilson JD, Auchus RJ, Leihy MW, et al. 5a-androstane-3a,17b-diol is formed in tammar wallaby pouch young testes by a pathway involving 5a-pregnane- 3a,17a-diol-20-one as a key intermediate. Endocrinology 2003; 144:575-580.
10. Arlt W, Walker EA, Draper N, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 2004; 363:2128-2135. (Pubitemid 38844154)
11. Shackleton C, Marcos J, Arlt W, Hauffa BP. Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. Am J Med Genet A 2004; 129:105-112. (Pubitemid 39121274)
12. Shackleton C, Marcos J, Malunowicz EM, et al. Biochemical diagnosis of Antley-Bixler syndrome by steroid analysis. Am J Med Genet A 2004; 128:223-231. (Pubitemid 38849889)
13. Homma K, Hasegawa T, Nagai T, et al. Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab 2006; 91:2643-2649. (Pubitemid 44024631)
14. Auchus RJ. The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 2004; 15:432-438.
15. Ghayee HK, Auchus RJ. Clinical implications of androgen synthesis via 5a-reduced precursors. Endocr Dev 2008; 13:55-66.
16. Nebesio TD, Eugster EA. Observation of hypertension in children with 21- hydroxylase deficiency: a preliminary report. Endocrine 2006; 30:279-282.
17. Falhammar H, Filipsson H, Holmdahl G, et al. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21- hydroxylase deficiency. J Clin Endocrinol Metab 2007; 92:110-116. (Pubitemid 46067517)
18. Løvås K, Husebye ES. Replacement therapy for Addison's disease: recent developments. Expert Opin Investig Drugs 2008; 17:497-509. (Pubitemid 351578168)
19. Merke DP, Cho D, Calis KA, et al. Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86:441-445. (Pubitemid 32109832)
20. Charmandari E, Matthews DR, Johnston A, et al. Serum cortisol and 17- hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 2001; 86:4679-4685. (Pubitemid 33020506)
21. Caldato MC, Fernandes VT, Kater CE. One-year clinical evaluation of single morning dose prednisolone therapy for 21-hydroxylase deficiency. Arq Bras Endocrinol Metabol 2004; 48:705-712.
22. Debono M, Ghobadi C, Rostami-Hodjegan A, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab 2009; 94:1548-1554.
23. Merke DP. Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008; 93:653-660. (Pubitemid 351398534)
24. Ravichandran R, Lafferty F, McGinniss MJ, Taylor HC. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 1996; 81:1776-1779. (Pubitemid 26152462)
25. Falhammar H, Filipsson H, Holmdahl G, et al. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007; 92:4643-4649. (Pubitemid 350223439)
26. Sciannamblo M, Russo G, Cuccato D, et al. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91:4453-4458. (Pubitemid 44833422)
27. Kim MS, Merke DP. Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Semin Reprod Med 2009; 27:316-321.
28. Chakhtoura Z, Bachelot A, Samara-Boustani D, et al. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21- hydroxylase deficiency. Eur J Endocrinol 2008; 158:879-887. (Pubitemid 351837377)
29. Tiitinen A, Välimäki M. Primary infertility in 45-year-old man with untreated 21-hydroxylase deficiency: successful outcome with glucocorticoid therapy. J Clin Endocrinol Metab 2002; 87:2442-2445. (Pubitemid 34655297)
30. Cabrera MS, Vogiatzi MG, New MI. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86:3070-3078. (Pubitemid 32673467)
31. Claahsen-van der Grinten HL, Otten BJ, Hermus AR, et al. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage. Fertil Steril 2008; 89:597-601.
32. Reisch N, Flade L, Scherr M, et al. High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2009; 94:1665-1670.
33. Avila NA, Premkumar A, Merke DP. Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings. AJR Am J Roentgenol 1999; 172:1003-1006. (Pubitemid 29505628)
34. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Hermus AR. Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors. Fertil Steril 2007; 88:705 e5-705 e8.
35. Claahsen-van der Grinten HL, Otten BJ, Takahashi S, et al. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab 2007; 92:612-615. (Pubitemid 46255304)
36. Scaroni C, Favia G, Lumachi F, et al. Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment and surgery. Exp Clin Endocrinol Diabetes 2003; 111:41-43. (Pubitemid 36336815)
37. Charmandari E, Chrousos GP. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Ann N Y Acad Sci 2006; 1083:37-53. (Pubitemid 44955466)
38. Barnes RB, Rosenfield RL, Ehrmann DA, et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994; 79:1328-1333.
39. Merke DP, Keil MF, Jones JV, et al. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2000; 85:1114-1120.
40. Nordenskjöld A, Holmdahl G, Frisen L, et al. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2008; 93:380-386. (Pubitemid 351240807)
41. Gastaud F, Bouvattier C, Duranteau L, et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007; 92:1391-1396. (Pubitemid 46556415)
42. Rosenfield RL, Bickel S, Razdan AK. Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol 1980; 56:208-215. (Pubitemid 10035781)
43. Lo JC, Schwitzgebel VM, Tyrrell JB, et al. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84:930-936.
44. Casteràs A, De Silva P, Rumsby G, Conway GS. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 2009; 70:833-837.
45. Nimkarn S, New MI. Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol Cell Endocrinol 2009; 300:192-196. (Pubitemid 46650667)
46. Ogilvie CM, Rumsby G, Kurzawinski T, Conway GS. Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit's experience. Eur J Endocrinol 2006; 154:405-408.
47. Stikkelbroeck NM, Beerendonk CC, Willemsen WN, et al. The long term outcome of feminizing genital surgery for congenital adrenal hyperplasia: anatomical, functional and cosmetic outcomes, psychosexual development, and satisfaction in adult female patients. J Pediatr Adolesc Gynecol 2003; 16:289-296.
48. Lin WC, Chang CY, Shen YY, Tsai HD. Use of autologous buccal mucosa for vaginoplasty: a study of eight cases. Hum Reprod 2003; 18:604-607.
49. Samuelson ML, Baker LA. Autologous buccal mucosa vulvovaginoplasty for high urogenital sinus. J Pediatr Urol 2006; 2:486-488.